Khabor Wala Desk
Published: 18th January 2026, 3:52 PM
Intermittent fasting (IF), also known as periodic fasting, has gained considerable attention as a dietary approach for improving metabolic health. Advocates suggest that it may enhance insulin sensitivity, promote weight loss, and help regulate blood glucose levels. Numerous studies indicate that, particularly in individuals with type 2 diabetes, intermittent fasting can contribute to meaningful reductions in both HbA1c levels and body weight.
However, experts emphasise that without careful planning and medical supervision, intermittent fasting can pose significant risks for people living with diabetes.
For selected individuals with type 2 diabetes, intermittent fasting may improve insulin sensitivity and facilitate weight loss—both crucial for effective glycaemic control. By restricting eating to specific time windows, total calorie intake is often reduced, while metabolic flexibility may improve. Over time, this can lead to better control of blood sugar levels and reductions in HbA1c.
When implemented under medical guidance, intermittent fasting may serve as a supportive tool for diabetes management, complementing conventional dietary strategies and medication regimens.
| Benefit | Explanation | Notes |
|---|---|---|
| Improved insulin sensitivity | Cells respond more effectively to insulin | Important for glycaemic control |
| Weight reduction | Caloric intake decreases naturally | Supports metabolic health |
| Lower HbA1c | Average blood glucose improves over time | Requires consistent fasting adherence |
| Enhanced metabolic flexibility | Body adapts to alternating feeding and fasting states | May improve energy regulation |
Medical professionals caution that improperly executed intermittent fasting can trigger both hypoglycaemia (dangerously low blood sugar) and hyperglycaemia (elevated blood sugar).
Hypoglycaemia risk is especially pronounced in individuals taking insulin or potent glucose-lowering medications, as prolonged fasting without dose adjustments can have severe consequences.
Conversely, breaking fasts with high-sugar or refined carbohydrate-rich foods may cause sharp postprandial glucose spikes, negating the benefits of fasting.
Certain populations should avoid intermittent fasting altogether, including individuals with type 1 diabetes, pregnant or breastfeeding women, those with a history of eating disorders, or anyone with reduced awareness of hypoglycaemic symptoms.
Before beginning intermittent fasting, people with diabetes should consult their healthcare provider. Medication adjustments may be necessary, and personalised guidance is critical.
Regular blood glucose monitoring is essential for safety, allowing early detection of hypoglycaemia, assessment of dietary effects, and timely intervention. Continuous glucose monitoring systems can further enhance safety by providing real-time data during fasting periods.
In summary, while intermittent fasting may offer metabolic benefits for some individuals with type 2 diabetes, it is not a universal solution. Careful planning, medical oversight, and personalised implementation are essential to ensure both safety and effectiveness in diabetes management.
Comments